Advertisement
Screener

CVS HEALTH CORPORATION (CVS) Payments for (Proceeds from) Derivative Instrument, Financing Activities

2.8 / 5 stars · 68/120 Roast Me

CVS HEALTH CORPORATION Payments for (Proceeds from) Derivative Instrument, Financing Activities

CVS HEALTH CORPORATION (CVS) reported Payments for (Proceeds from) Derivative Instrument, Financing Activities of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-09.

Discontinued › Cash Flow › Financing Activities

us-gaap:PaymentsForProceedsFromDerivativeInstrumentFinancingActivities · last filed 2022-02-09

  • CVS HEALTH CORPORATION payments for (proceeds from) derivative instrument, financing activities for the quarter ending 2021-12-31 was $0.00.
  • CVS HEALTH CORPORATION payments for (proceeds from) derivative instrument, financing activities for the quarter ending 2020-12-31 was $0.00.
  • CVS HEALTH CORPORATION payments for (proceeds from) derivative instrument, financing activities for the quarter ending 2020-03-31 was $7.00M.
  • CVS HEALTH CORPORATION payments for (proceeds from) derivative instrument, financing activities for the quarter ending 2019-12-31 was $0.00.
  • CVS HEALTH CORPORATION payments for (proceeds from) derivative instrument, financing activities for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
  • CVS HEALTH CORPORATION payments for (proceeds from) derivative instrument, financing activities for fiscal 2020 was $7.00M, a 72.00% decline from fiscal 2019.
  • CVS HEALTH CORPORATION payments for (proceeds from) derivative instrument, financing activities for fiscal 2019 was $25.00M.
  • CVS HEALTH CORPORATION payments for (proceeds from) derivative instrument, financing activities for fiscal 2018 was -$446.00M.
Period endPayments for (Proceeds from) Derivative Instrument, Financing ActivitiesPayments for (Proceeds from) Derivative Instrument, Financing Activities 1 monthPayments for (Proceeds from) Derivative Instrument, Financing Activities 3 monthPayments for (Proceeds from) Derivative Instrument, Financing Activities 3 month as first filedPayments for (Proceeds from) Derivative Instrument, Financing Activities 6 monthPayments for (Proceeds from) Derivative Instrument, Financing Activities 9 monthPayments for (Proceeds from) Derivative Instrument, Financing Activities 12 month
2021-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-09
$0.00
10-K · filed 2022-02-09
2021-09-30$0.00
10-Q · filed 2021-11-03
2020-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-09
$7.00M
10-K · filed 2022-02-09
2020-09-30$7.00M
10-Q · filed 2021-11-03
2020-03-31$7.00M
10-Q · filed 2020-11-06
$7.00M
10-K · filed 2022-02-09
$7.00M
derived: sum of 2 quarters · filed 2022-02-09
$32.00M
derived: sum of 3 quarters · filed 2022-02-09
$32.00M
derived: sum of 4 quarters · filed 2022-02-09
2019-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-09
$25.00M
derived: sum of 2 quarters · filed 2022-02-09
$25.00M
derived: sum of 3 quarters · filed 2022-02-09
$25.00M
10-K · filed 2022-02-09
2019-09-30$25.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06
$25.00M
derived: sum of 2 quarters · filed 2020-11-06
$25.00M
10-Q · filed 2020-11-06
$25.00M
derived: sum of 4 quarters · filed 2021-02-16
2019-07-31$25.00M
10-K · filed 2021-02-16
2019-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07
$0.00
10-Q · filed 2019-08-07
$0.00
derived: sum of 3 quarters · filed 2021-02-16
$0.00
derived: sum of 4 quarters · filed 2021-02-16
2019-03-31$0.00
10-Q · filed 2019-05-01
$0.00
derived: sum of 2 quarters · filed 2021-02-16
$0.00
derived: sum of 3 quarters · filed 2021-02-16
-$892.00M
derived: sum of 4 quarters · filed 2021-02-16
2018-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16
$0.00
derived: sum of 2 quarters · filed 2021-02-16
-$892.00M
derived: sum of 3 quarters · filed 2021-02-16
-$446.00M
10-K · filed 2021-02-16
2018-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06
-$892.00M
derived: sum of 2 quarters · filed 2019-11-06
-$446.00M
10-Q · filed 2019-11-06
2018-06-30-$892.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07
-$446.00M
10-Q · filed 2019-08-07
2018-03-31$446.00M
10-Q · filed 2019-05-01
-$446.00M
10-Q · filed 2018-05-02
2018-03-09-$446.00M
10-Q · filed 2018-11-06
2017-12-31$0.00
10-K · filed 2020-02-18
2016-12-31$0.00
8-K · filed 2019-08-08

Similar stocks

Stock NameCountryMarket CapPE Ratio
PETMED EXPRESS INC (PETS)United States$0.034B-1.41